Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX vs placebo for masseter hypertrophy
CTR20191352Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in masseter hypertrophy, sponsored by AbbVie Inc.. Started Jul 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
masseter hypertrophy
Beyond the preview
Go deeper on CTR20191352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191352.